rotigotine FDA Link

Antiparkinson Agent and dopamine receptor agonist; structure given in first source; RN given refers to cpd without isomeric designation

Also Known As:

(+)- 5,6,7,8- tetrahydro- 6- (propyl(2- (2- thienyl)ethyl)amino)- 1- naphthol; (+- - )- 5,6,7,8- tetrahydro- 6- (propyl(2- (2- thienyl)ethyl)amino)- 1- naphthol; 1-naphthalenol, 5,6,7,8- tetrahydro- 6- (propyl(2- (2- thienyl)ethyl)amino)- ; 2- (N- n- propyl- N- 2- thienylethylamino)- 5- hydroxytetralin; N 0437; N 0437, (+-)-isomer; N 0437, (-)-isomer; N 0437, (R)-isomer; N 0437, hydrochloride, (R)-isomer; N 0437, hydrochloride, (S)-isomer; N 0923; N 0924; N-0437; N-0923; N-0924; Neupro; Rotigotine CDS; racemic N-0437; rotigotine (+-)-form; rotigotine, (+)-; rotigotine, (+--)-

Pharmalogical Action Categories:

D018491 - Dopamine Agonists

Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        rotigotine: 323
- Sulfur Compounds: 283
  - Thiophenes: 266
    - rotigotine: 323
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - rotigotine: 323
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Thiophenes: 266
    - rotigotine: 323

Pietro Lucca Ratti Selected Research

Pietro Lucca Ratti Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure